New In-Depth Report on Demand and Supply for Contract Manufacturing of Conventional Injectable Drugs Through 2019
PharmSource, the acknowledged authority on bio/pharmaceutical contract manufacturing, has released an extensive study on the supply and demand for contract injectable manufacturing through 2019. This important analysis provides invaluable information for CMOs, pharmaceutical sourcing executives and others on the latest trends for outsourcing of commercially approved injectable products by the major pharmaceutical and biopharmaceutical companies.
FAIRFAX, VA. December 6, 2013 – In their latest Special Report, “The Demand and Supply for Contract Manufacturing of Conventional Injectable Drugs Through 2019,” PharmSource experts provide a quantitative analysis on the latest trends and plans for outsourcing commercially approved injectable products.
Founded on the industry’s most comprehensive database of the dose CMO industry – PharmSource’sStrategic Advantage Database of Contract Service Providers – the analytical model and assumptions are fully explained so readers can understand how the analysis and conclusions were established. PharmSource is considered to be
the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
Projections are presented for key processing capabilities, including aseptic fill, lyophilized vials and prefilled devices such as syringes, cartridges and proprietary devices. The study analyzes the current capacity and planned additions to capacity of contract manufacturers, as well as the plans by major sponsors to increase in-house capacity.
This 80-page report gives important, expert insight that is not available in any other source. Over 25 tables and more than 20 charts and graphs throughout the report illustrate major points and trends. This report should be required reading for:
- CMO executives: this report is an indispensable resource for understanding the industry and a critical input for strategic planning efforts.
- Sourcing and procurement executives: this report is a critical resource for understanding crucial components of the supply base that will provide insights for supplier selection and management.
- Private equity investors: this report gives a deeper understanding of the market and important insight for identifying potential investment targets.
For more information, contact PharmSource directly at +1-703-383-4903 / email@example.com.